169 related articles for article (PubMed ID: 29162222)
1. Impact of Solid Minor Histologic Subtype in Postsurgical Prognosis of Stage I Lung Adenocarcinoma.
Chen T; Luo J; Gu H; Gu Y; Huang Q; Wang Y; Zheng J; Yang Y; Chen H
Ann Thorac Surg; 2018 Jan; 105(1):302-308. PubMed ID: 29162222
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and predictive value of the novel classification of lung adenocarcinoma in patients with stage IB.
Luo J; Huang Q; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Wang Y; Zheng J; Wu H; Xia W; Chen H
J Cancer Res Clin Oncol; 2016 Sep; 142(9):2031-40. PubMed ID: 27379889
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma.
Qian F; Yang W; Wang R; Xu J; Wang S; Zhang Y; Jin B; Yu K; Han B
J Thorac Cardiovasc Surg; 2018 Mar; 155(3):1227-1235.e2. PubMed ID: 29223834
[TBL] [Abstract][Full Text] [Related]
4. Solid predominant histologic subtype and early recurrence predict poor postrecurrence survival in patients with stage I lung adenocarcinoma.
Luo J; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Huang Q; Wang Y; Zheng J; Chen H
Oncotarget; 2017 Jan; 8(4):7050-7058. PubMed ID: 27732964
[TBL] [Abstract][Full Text] [Related]
5. Solid component and tumor size correlate with prognosis of stage IB lung adenocarcinoma.
Xu S; Xi J; Jiang W; Lu S; Wang Q
Ann Thorac Surg; 2015 Mar; 99(3):961-7. PubMed ID: 25633461
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant Chemotherapy Improves the Probability of Freedom From Recurrence in Patients With Resected Stage IB Lung Adenocarcinoma.
Hung JJ; Wu YC; Chou TY; Jeng WJ; Yeh YC; Hsu WH
Ann Thorac Surg; 2016 Apr; 101(4):1346-53. PubMed ID: 26794883
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Role of Subtype Classification in Small-Sized Pathologic N0 Invasive Lung Adenocarcinoma.
Yoshiya T; Mimae T; Tsutani Y; Tsubokawa N; Sasada S; Miyata Y; Kushitani K; Takeshima Y; Murakami S; Ito H; Nakayama H; Okada M
Ann Thorac Surg; 2016 Nov; 102(5):1668-1673. PubMed ID: 27344277
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of the international association for the study of lung cancer/American Thoracic Society/European Respiratory Society classification of lung adenocarcinoma in tumor recurrence and patient survival.
Hung JJ; Yeh YC; Jeng WJ; Wu KJ; Huang BS; Wu YC; Chou TY; Hsu WH
J Clin Oncol; 2014 Aug; 32(22):2357-64. PubMed ID: 24799473
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive evaluation of clinicopathologic characteristics, molecular features and prognosis in lung adenocarcinoma with solid component.
Li J; You W; Zheng D; Yan B; Ma X; Pan Y; Zhang Y; Li Y; Shen X; Cheng X; Sun Y; Chen H
J Cancer Res Clin Oncol; 2018 Apr; 144(4):725-734. PubMed ID: 29368062
[TBL] [Abstract][Full Text] [Related]
10. The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival.
Warth A; Muley T; Meister M; Stenzinger A; Thomas M; Schirmacher P; Schnabel PA; Budczies J; Hoffmann H; Weichert W
J Clin Oncol; 2012 May; 30(13):1438-46. PubMed ID: 22393100
[TBL] [Abstract][Full Text] [Related]
11. Solid Predominant Histologic Subtype in Resected Stage I Lung Adenocarcinoma Is an Independent Predictor of Early, Extrathoracic, Multisite Recurrence and of Poor Postrecurrence Survival.
Ujiie H; Kadota K; Chaft JE; Buitrago D; Sima CS; Lee MC; Huang J; Travis WD; Rizk NP; Rudin CM; Jones DR; Adusumilli PS
J Clin Oncol; 2015 Sep; 33(26):2877-84. PubMed ID: 26261257
[TBL] [Abstract][Full Text] [Related]
12. Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection.
Tsao MS; Marguet S; Le Teuff G; Lantuejoul S; Shepherd FA; Seymour L; Kratzke R; Graziano SL; Popper HH; Rosell R; Douillard JY; Le-Chevalier T; Pignon JP; Soria JC; Brambilla EM
J Clin Oncol; 2015 Oct; 33(30):3439-46. PubMed ID: 25918286
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification on death and recurrence in completely resected stage I lung adenocarcinoma.
Hung JJ; Jeng WJ; Chou TY; Hsu WH; Wu KJ; Huang BS; Wu YC
Ann Surg; 2013 Dec; 258(6):1079-86. PubMed ID: 23532112
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of the IASLC/ATS/ERS classification in stage I lung adenocarcinoma patients--based on a hospital study in China.
Song Z; Zhu H; Guo Z; Wu W; Sun W; Zhang Y
Eur J Surg Oncol; 2013 Nov; 39(11):1262-8. PubMed ID: 24063970
[TBL] [Abstract][Full Text] [Related]
15. Modified histologic classification as a prognostic factor in pulmonary adenocarcinoma.
Hwang I; Park KU; Kwon KY
Int J Surg Pathol; 2014 May; 22(3):212-20. PubMed ID: 24599899
[TBL] [Abstract][Full Text] [Related]
16. Predictors of recurrence and survival of pathological T1N0M0 invasive adenocarcinoma following lobectomy.
Wang Y; Zheng D; Zheng J; Huang Q; Han B; Zhang J; Zhao H; Chen H
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1015-1023. PubMed ID: 29532227
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification in stage IB lung adenocarcinoma.
Xu CH; Wang W; Wei Y; Hu HD; Zou J; Yan J; Yu LK; Yang RS; Wang Y
Eur J Surg Oncol; 2015 Oct; 41(10):1430-6. PubMed ID: 26123994
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of histology in resected lung cancer with emphasis on the relevance of the adenocarcinoma subtyping.
Riquet M; Foucault C; Berna P; Assouad J; Dujon A; Danel C
Ann Thorac Surg; 2006 Jun; 81(6):1988-95. PubMed ID: 16731118
[TBL] [Abstract][Full Text] [Related]
19. Minor Components of Micropapillary and Solid Subtypes in Lung Adenocarcinoma are Predictors of Lymph Node Metastasis and Poor Prognosis.
Zhao Y; Wang R; Shen X; Pan Y; Cheng C; Li Y; Shen L; Zhang Y; Li H; Zheng D; Ye T; Zheng S; Sun Y; Chen H
Ann Surg Oncol; 2016 Jun; 23(6):2099-105. PubMed ID: 26842488
[TBL] [Abstract][Full Text] [Related]
20. Primary adenocarcinoma of the lung--histological subtypes and outcome after surgery, using the IASLC/ATS/ERS classification of lung adenocarcinoma.
Oskarsdottir GN; Bjornsson J; Jonsson S; Isaksson HJ; Gudbjartsson T
APMIS; 2016 May; 124(5):384-92. PubMed ID: 26957057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]